• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Serum Amyloid A Level in Egyptian Children with Familial Mediterranean Fever.患有家族性地中海热的埃及儿童的血清淀粉样蛋白A水平
Int J Rheumatol. 2016;2016:7354018. doi: 10.1155/2016/7354018. Epub 2016 Dec 13.
2
Concordance between CRP and SAA in familial Mediterranean fever during attack-free period: A study of 218 patients.发作间期家族性地中海热中CRP与SAA的一致性:一项对218例患者的研究
Clin Biochem. 2017 Mar;50(4-5):206-209. doi: 10.1016/j.clinbiochem.2016.11.008. Epub 2016 Nov 10.
3
The Value of Serum Amyloid A Levels in Familial Mediterranean Fever to Identify Occult Inflammation During Asymptomatic Periods.血清淀粉样蛋白 A 水平在家族性地中海热无症状期识别隐匿性炎症中的价值。
J Clin Rheumatol. 2021 Jan 1;27(1):1-4. doi: 10.1097/RHU.0000000000001134.
4
A single testing of serum amyloid a levels as a tool for diagnosis and treatment dilemmas in familial Mediterranean fever.单次检测血清淀粉样蛋白a水平作为家族性地中海热诊断和治疗困境的一种工具。
Semin Arthritis Rheum. 2007 Dec;37(3):182-8. doi: 10.1016/j.semarthrit.2007.03.005. Epub 2007 May 23.
5
Role of A-SAA in monitoring subclinical inflammation and in colchicine dosage in familial Mediterranean fever.A-SAA在监测家族性地中海热亚临床炎症及秋水仙碱剂量调整中的作用
Clin Exp Rheumatol. 2003 Jul-Aug;21(4):509-14.
6
Serum amyloid A as a biomarker in differentiating attacks of familial Mediterranean fever from acute febrile infections.血清淀粉样蛋白 A 作为区分家族性地中海热发作与急性发热感染的生物标志物。
Clin Rheumatol. 2020 Jan;39(1):249-253. doi: 10.1007/s10067-019-04765-1. Epub 2019 Sep 4.
7
The value of the levels of acute phase reactants for the prediction of familial Mediterranean fever associated amyloidosis: a case control study.急性期反应物水平对家族性地中海热相关淀粉样变性预测的价值:一项病例对照研究。
Rheumatol Int. 2007 Apr;27(6):517-22. doi: 10.1007/s00296-006-0265-6. Epub 2006 Nov 14.
8
Evaluation of S100A12 protein levels in children with familial Mediterranean fever.评估家族性地中海热患儿 S100A12 蛋白水平。
Turk J Med Sci. 2021 Jun 28;51(3):1396-1405. doi: 10.3906/sag-2009-187.
9
Is there a relationship between serum omentin level and acute phase response in patients with familial Mediterranean fever?家族性地中海热患者血清网膜素水平与急性期反应之间存在关联吗?
Clin Rheumatol. 2021 Feb;40(2):669-674. doi: 10.1007/s10067-020-05249-3. Epub 2020 Jul 4.
10
R202Q/M694V as novel MEFV gene mutations in chronic periodontitis and familial Mediterranean fever.R202Q/M694V 作为慢性牙周炎和家族性地中海热中新型 MEFV 基因突变。
J Periodontal Res. 2017 Dec;52(6):994-1003. doi: 10.1111/jre.12467. Epub 2017 Jun 7.

引用本文的文献

1
Analysis of the Effects of SAA1 Gene Polymorphisms on Renal Involvement in a Familial Mediterranean Fever Jordanian Population.SAA1基因多态性对约旦家族性地中海热患者肾脏受累影响的分析
Eurasian J Med. 2024 Sep 24;56(3):153-158. doi: 10.5152/eurasianjmed.2024.24457.
2
Serum amyloid A-A potential therapeutic target for hyper-inflammatory syndrome associated with COVID-19.血清淀粉样蛋白A——新型冠状病毒肺炎相关高炎症综合征的潜在治疗靶点
Front Med (Lausanne). 2023 Mar 16;10:1135695. doi: 10.3389/fmed.2023.1135695. eCollection 2023.
3
Genetic and Epigenetic Regulation of MEFV Gene and Their Impact on Clinical Outcome in Auto-Inflammatory Familial Mediterranean Fever Patients.MEFV基因的遗传和表观遗传调控及其对自身炎症性家族性地中海热患者临床结局的影响
Curr Issues Mol Biol. 2023 Jan 13;45(1):721-737. doi: 10.3390/cimb45010048.
4
Cardiac repolarization abnormalities in children with familial Mediterranean fever.家族性地中海热患儿的心脏复极异常。
Pediatr Rheumatol Online J. 2022 May 23;20(1):38. doi: 10.1186/s12969-022-00696-5.
5
Serum Amyloid A in Inflammatory Rheumatic Diseases: A Compendious Review of a Renowned Biomarker.血清淀粉样蛋白 A 在炎症性风湿性疾病中的作用:著名生物标志物的简明综述。
Front Immunol. 2021 Feb 19;11:631299. doi: 10.3389/fimmu.2020.631299. eCollection 2020.
6
[Results of the systematic literature search as basis for the "Evidence-based treatment recommendations for familial Mediterranean fever patients with insufficient response or intolerability to colchicine" of the Society for Pediatric and Adolescent Rheumatology and the German Society for Rheumatology].[作为儿科和青少年风湿病学会以及德国风湿病学会“对秋水仙碱反应不足或不耐受的家族性地中海热患者的循证治疗建议”依据的系统文献检索结果]
Z Rheumatol. 2020 Nov;79(9):943-951. doi: 10.1007/s00393-020-00886-0. Epub 2020 Sep 30.

本文引用的文献

1
Diagnostic criteria of familial Mediterranean fever.家族性地中海热的诊断标准。
Autoimmun Rev. 2014 Apr-May;13(4-5):388-90. doi: 10.1016/j.autrev.2014.01.045. Epub 2014 Jan 11.
2
Renal amyloidosis in children.儿童肾淀粉样变性。
Pediatr Nephrol. 2011 Aug;26(8):1215-27. doi: 10.1007/s00467-011-1797-x. Epub 2011 Mar 1.
3
Anti-interleukin 1 treatment for patients with familial Mediterranean fever resistant to colchicine.抗白细胞介素 1 治疗对秋水仙碱耐药的家族性地中海热患者。
J Rheumatol. 2011 Mar;38(3):516-8. doi: 10.3899/jrheum.100718. Epub 2010 Dec 15.
4
About colchicine compliance, resistance and virulence.关于秋水仙碱的依从性、耐药性和毒性。
Clin Exp Rheumatol. 2009 Mar-Apr;27(2 Suppl 53):S1-3.
5
Familial mediterranean Fever in the world.全球范围内的家族性地中海热。
Arthritis Rheum. 2009 Oct 15;61(10):1447-53. doi: 10.1002/art.24458.
6
A new set of criteria for the diagnosis of familial Mediterranean fever in childhood.一套新的儿童家族性地中海热诊断标准。
Rheumatology (Oxford). 2009 Apr;48(4):395-8. doi: 10.1093/rheumatology/ken509. Epub 2009 Feb 4.
7
Familial Mediterranean Fever: a review for clinical management.家族性地中海热:临床管理综述
Joint Bone Spine. 2009 May;76(3):227-33. doi: 10.1016/j.jbspin.2008.08.004. Epub 2008 Dec 16.
8
Familial Mediterranean fever: clinical, molecular and management advancements.家族性地中海热:临床、分子及管理方面的进展
Neth J Med. 2007 Oct;65(9):318-24.
9
A single testing of serum amyloid a levels as a tool for diagnosis and treatment dilemmas in familial Mediterranean fever.单次检测血清淀粉样蛋白a水平作为家族性地中海热诊断和治疗困境的一种工具。
Semin Arthritis Rheum. 2007 Dec;37(3):182-8. doi: 10.1016/j.semarthrit.2007.03.005. Epub 2007 May 23.
10
Colchicine use in children and adolescents with familial Mediterranean fever: literature review and consensus statement.秋水仙碱在患有家族性地中海热的儿童和青少年中的应用:文献综述与共识声明
Pediatrics. 2007 Feb;119(2):e474-83. doi: 10.1542/peds.2006-1434. Epub 2007 Jan 22.

患有家族性地中海热的埃及儿童的血清淀粉样蛋白A水平

Serum Amyloid A Level in Egyptian Children with Familial Mediterranean Fever.

作者信息

Lofty Hala M, Marzouk Huda, Farag Yomna, Nabih Mohammad, Khalifa Iman A S, Mostafa Noha, Salah Ahmed, Rashed Laila, El Garf Kamal

机构信息

Department of Pediatrics, Faculty of Medicine, Cairo University, Cairo, Egypt.

Department of Medical Biochemistry, Faculty of Medicine, Cairo University, Cairo, Egypt.

出版信息

Int J Rheumatol. 2016;2016:7354018. doi: 10.1155/2016/7354018. Epub 2016 Dec 13.

DOI:10.1155/2016/7354018
PMID:28070191
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5187476/
Abstract

. SAA is an acute-phase reactant detected during an FMF attack or other inflammatory conditions. High SAA levels may increase the risk of amyloidosis. The aim of the study is to measure the serum amyloid A (SAA) level in a group of Egyptian children with familial Mediterranean fever (FMF) and study its various correlates, if any. . The study enrolled seventy-one children with FMF. . SAA level was high in 78.9% of the studied patients with a mean of 81.62 ± 31.6 mg/L, and CRP was positive in 31% of patients. There was no significant releation between SAA level and any demographic or clinical manifestation. High SAA was more frequent in V726A allele (16.9%) followed by M694V allele (12.3%). Elevated SAA levels were more frequent in patients on low colchicine doses. Forty-five percent (45%) of patients have low adherence to colchicine therapy. . High SAA levels were detected two weeks after last FMF attack in a large percentage of Egyptian FMF children. This indicates that subclinical inflammation continues during attack-free periods, and SAA could be used as a marker of it.

摘要

血清淀粉样蛋白A(SAA)是在家族性地中海热(FMF)发作或其他炎症状态下检测到的一种急性期反应物。高SAA水平可能会增加淀粉样变性的风险。本研究的目的是测量一组患有家族性地中海热(FMF)的埃及儿童的血清淀粉样蛋白A(SAA)水平,并研究其各种相关性(如果存在的话)。本研究纳入了71名患有FMF的儿童。在78.9%的研究患者中SAA水平较高,平均为81.62±31.6mg/L,31%的患者C反应蛋白(CRP)呈阳性。SAA水平与任何人口统计学或临床表现之间均无显著相关性。V726A等位基因中高SAA更为常见(16.9%),其次是M694V等位基因(12.3%)。低剂量秋水仙碱治疗的患者中SAA水平升高更为常见。45%的患者对秋水仙碱治疗依从性差。在很大比例的埃及FMF儿童中,在最后一次FMF发作两周后检测到高SAA水平。这表明在无发作期亚临床炎症仍在持续,SAA可作为其标志物。